Search - tctmd.com

Displaying 421 - 440 of 625

Sort: Relevancy | Date

Presentation TCT 2017

The Problem: Variability in SHD Image Quality and Its Impact on Procedural Outcomes

Presenter: G. Burkhard Mackensen, Robert J. Siegel, Paul A. Grayburn

November 01, 2017

Presentation TCT 2017

MAVERIC: 6-Month Outcomes of Transcatheter MV Repair in Patients With Severe Secondary Mitral Regurgitation

Presenter: Francesco Maisano, Stephen G. Worthley

November 01, 2017

Presentation TCT 2017

A Pregnant Woman With Severe Prosthetic Valve Stenosis

Presenter: Alfredo Trento, Jeffrey J. Popma

November 01, 2017

Presentation TCT 2017

Topic 2: Protect the Brain Cerebral Protection During TAVR Should Be Routine CON!

Presenter: Adrian P. Banning, Ted Feldman, Daniel J. Blackman

November 01, 2017

Presentation TCT 2017

Fantastic Voyage: Macrotrends in Microsystems for Transcatheter Therapeutics

Presenter: Gary S. Mintz, Giora Weisz, Charles C. Chung

November 01, 2017

Presentation TCT 2017

TRACER: 6-Month Outcomes of Transcatheter MV Neochordal Repair in Patients With Severe Primary Mitral Regurgitation

Presenter: Francesco Maisano, James S. Gammie

November 01, 2017

Presentation TCT 2017

When to Use Cerebral Protection During TAVR

Presenter: Alfredo Trento, Alexandra J. Lansky

November 01, 2017

Presentation TCT 2017

Topic 2: Protect the Brain Cerebral Protection During TAVR Should Be Routine - PRO!

Presenter: Adrian P. Banning, Ted Feldman, Eberhard Grube

November 01, 2017

Presentation TCT 2017

Options for Aortic Stenosis and Prosthesis-Patient Mismatch: Reoperation, Fracture, Supra-annular Valve, Balloon Valvuloplasty, Other

Presenter: Alfredo Trento, David J. Cohen

November 01, 2017

Presentation TCT 2017

What More Does the Heart Team Imager Need (Standards, Training, Community)?

Presenter: Rebecca T. Hahn, Stephen H. Little

November 01, 2017

Presentation TCT 2017

TENDYNE: 1-Year Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Regurgitation

Presenter: Francesco Maisano, David W.M. Muller

November 01, 2017

Presentation TCT 2017

INTREPID: 30-Day Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Regurgitation

Presenter: Francesco Maisano, Paul Sorajja

November 01, 2017

Presentation TCT 2017

Topic 1: Anticoagulation After TAVR Should Now be Standard of Care CON!

Presenter: Adrian P. Banning, Ted Feldman, Bernard Prendergast

November 01, 2017

Presentation TCT 2017

Post-TAVR Valve Thickening: Current Data and Open Questions

Presenter: Jonathon A. Leipsic, Maurice E. Sarano, Hasan Jilaihawi

November 01, 2017

Presentation TCT 2017

Topic 1: Anticoagulation After TAVR Should Now be Standard of Care PRO!

Presenter: Adrian P. Banning, Ted Feldman, Raj Makkar

November 01, 2017

Presentation TCT 2017

Venezuela Presents: A Complex Vascular Complication During TAVI - Solution and Lessons Learned

Presenter: Waqar H. Ahmed, Oscar A. Mendiz, Carlos D Calderas

November 01, 2017

Presentation TCT 2017

Approval Pathways for Transcatheter Mitral and Tricuspid Valve Therapies

Presenter: Steven F. Bolling, John C Laschinger, Bernard Vasseur

October 31, 2017

Presentation TCT 2017

Transcatheter Mitral Valve Replacement Device Trials: Regulatory Approval Trial Design Considerations

Presenter: Steven F. Bolling, John C Laschinger, Martin B. Leon

October 31, 2017

Presentation TCT 2017

Transcatheter FMR Mitral Valve Repair Device Trials for Regulatory Approval Post-COAPT: Lessons Learned, Future Directions

Presenter: Steven F. Bolling, John C Laschinger, Ori Ben-Yehuda

October 31, 2017

Presentation TCT 2017

FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices

Presenter: Martin B. Leon, Changfu Wu, John C Laschinger

October 31, 2017

Advertisement

The Problem: Variability in SHD Image Quality and Its Impact on Procedural Outcomes

MAVERIC: 6-Month Outcomes of Transcatheter MV Repair in Patients With Severe Secondary Mitral Regurgitation

A Pregnant Woman With Severe Prosthetic Valve Stenosis

Topic 2: Protect the Brain Cerebral Protection During TAVR Should Be Routine CON!

Fantastic Voyage: Macrotrends in Microsystems for Transcatheter Therapeutics

TRACER: 6-Month Outcomes of Transcatheter MV Neochordal Repair in Patients With Severe Primary Mitral Regurgitation

When to Use Cerebral Protection During TAVR

Topic 2: Protect the Brain Cerebral Protection During TAVR Should Be Routine - PRO!

Options for Aortic Stenosis and Prosthesis-Patient Mismatch: Reoperation, Fracture, Supra-annular Valve, Balloon Valvuloplasty, Other

What More Does the Heart Team Imager Need (Standards, Training, Community)?

TENDYNE: 1-Year Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Regurgitation

INTREPID: 30-Day Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Regurgitation

Topic 1: Anticoagulation After TAVR Should Now be Standard of Care CON!

Post-TAVR Valve Thickening: Current Data and Open Questions

Topic 1: Anticoagulation After TAVR Should Now be Standard of Care PRO!

Venezuela Presents: A Complex Vascular Complication During TAVI - Solution and Lessons Learned

Approval Pathways for Transcatheter Mitral and Tricuspid Valve Therapies

Transcatheter Mitral Valve Replacement Device Trials: Regulatory Approval Trial Design Considerations

Transcatheter FMR Mitral Valve Repair Device Trials for Regulatory Approval Post-COAPT: Lessons Learned, Future Directions

FDA Perspectives on TAVR Label Expansion Using Real-World Evidence, Valve Degeneration, and Embolic Protection Devices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content